Smith, Moore & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Buy |
576
+3
| +0.5% | +$1.22K | 0.02% | 448 |
|
|
2025
Q1 | $285K | Buy |
+573
| New | +$285K | 0.03% | 387 |
|
|
2023
Q3 | – | Sell |
-1,711
| Closed | -$893K | – | 400 |
|
|
2023
Q2 | $893K | Buy |
1,711
+44
| +3% | +$23K | 0.11% | 164 |
|
|
2023
Q1 | $961K | Buy |
1,667
+95
| +6% | +$54.8K | 0.13% | 145 |
|
|
2022
Q4 | $866K | Buy |
1,572
+77
| +5% | +$42.4K | 0.12% | 163 |
|
|
2022
Q3 | $758K | Buy |
1,495
+81
| +6% | +$41.1K | 0.12% | 165 |
|
|
2022
Q2 | $768K | Buy |
1,414
+61
| +5% | +$33.1K | 0.12% | 174 |
|
|
2022
Q1 | $799K | Hold |
1,353
| – | – | 0.11% | 187 |
|
|
2021
Q4 | $903K | Buy |
1,353
+85
| +7% | +$56.7K | 0.13% | 168 |
|
|
2021
Q3 | $725K | Sell |
1,268
-72
| -5% | -$41.2K | 0.11% | 187 |
|
|
2021
Q2 | $676K | Buy |
1,340
+13
| +1% | +$6.56K | 0.1% | 201 |
|
|
2021
Q1 | $606K | Sell |
1,327
-35
| -3% | -$16K | 0.1% | 206 |
|
|
2020
Q4 | $634K | Sell |
1,362
-132
| -9% | -$61.4K | 0.12% | 176 |
|
|
2020
Q3 | $660K | Sell |
1,494
-15
| -1% | -$6.63K | 0.14% | 150 |
|
|
2020
Q2 | $547K | Sell |
1,509
-202
| -12% | -$73.2K | 0.12% | 156 |
|
|
2020
Q1 | $485K | Buy |
1,711
+118
| +7% | +$33.4K | 0.13% | 154 |
|
|
2019
Q4 | $518K | Sell |
1,593
-47
| -3% | -$15.3K | 0.11% | 171 |
|
|
2019
Q3 | $478K | Buy |
1,640
+54
| +3% | +$15.7K | 0.11% | 177 |
|
|
2019
Q2 | $466K | Buy |
1,586
+7
| +0.4% | +$2.06K | 0.1% | 190 |
|
|
2019
Q1 | $432K | Sell |
1,579
-89
| -5% | -$24.4K | 0.1% | 197 |
|
|
2018
Q4 | $373K | Buy |
1,668
+311
| +23% | +$69.5K | 0.1% | 202 |
|
|
2018
Q3 | $331K | Sell |
1,357
-31
| -2% | -$7.56K | 0.08% | 234 |
|
|
2018
Q2 | $288K | Buy |
1,388
+179
| +15% | +$37.1K | 0.07% | 247 |
|
|
2018
Q1 | $250K | Buy |
+1,209
| New | +$250K | 0.07% | 259 |
|